News
Luminate NY Accelerator Cohort 9 Start-Ups Announced
Overview
Empire State Development (ESD) announced the 10 startups chosen for round nine of the New York State supported Luminate NY accelerator, investment fund, and competition. Cohort nine is solving challenges through novel deep technology that is applicable to a number of industries, including, but not limited to: life sciences, augmented/virtual reality, advanced manufacturing, and sensing and monitoring.
In This Article
Start-ups selected with life sciences and health connections include:
Phlotonics, based in Rochester, New York empowers advanced biomanufacturing and drug discovery through advanced photonic sensor platforms that provide real-time, label-free biomolecular analysis.
Ciconia Medical from San Diego, California improves women’s childbirth experiences and outcomes through the first AI-based medical device for vaginal exams.
Modendo from Boulder, Colorado offers ultrathin microscopes that comprise a single optical fiber and provide high-resolution imaging for industrial and medical applications.
The Big Picture
Luminate NY Managing Director Sujatha Ramanujan said, “These startups reflect Luminate NY’s standing as a premier global destination for deep-tech innovation. By connecting these visionary founders with our region’s unmatched OPI supply chain and technical expertise, we are not only accelerating the commercialization of life-changing technologies but also cementing the Finger Lakes’ position as the world’s epicenter for optics and photonics.” Optics and photonics innovation intersects many crucial industries, including the biosciences.
Since its inception, Luminate has invested $23 million in 85 startups. The companies in the portfolio have raised an additional $497 million and now share an estimated net worth of $725 million.
